267 related articles for article (PubMed ID: 17211471)
1. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.
Grunewald TG; Kammerer U; Winkler C; Schindler D; Sickmann A; Honig A; Butt E
Br J Cancer; 2007 Jan; 96(2):296-305. PubMed ID: 17211471
[TBL] [Abstract][Full Text] [Related]
2. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.
Grunewald TG; Kammerer U; Schulze E; Schindler D; Honig A; Zimmer M; Butt E
Exp Cell Res; 2006 Apr; 312(7):974-82. PubMed ID: 16430883
[TBL] [Abstract][Full Text] [Related]
3. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
4. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
5. Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1.
Li B; Zhuang L; Trueb B
J Biol Chem; 2004 May; 279(19):20401-10. PubMed ID: 15004028
[TBL] [Abstract][Full Text] [Related]
6. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
7. Lasp-1 regulates podosome function.
Stölting M; Wiesner C; van Vliet V; Butt E; Pavenstädt H; Linder S; Kremerskothen J
PLoS One; 2012; 7(4):e35340. PubMed ID: 22514729
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase.
Keicher C; Gambaryan S; Schulze E; Marcus K; Meyer HE; Butt E
Biochem Biophys Res Commun; 2004 Nov; 324(1):308-16. PubMed ID: 15465019
[TBL] [Abstract][Full Text] [Related]
9. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract][Full Text] [Related]
10. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
Shimizu F; Shiiba M; Ogawara K; Kimura R; Minakawa Y; Baba T; Yokota S; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e83187. PubMed ID: 24386158
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells.
Tang R; Kong F; Hu L; You H; Zhang P; Du W; Zheng K
Virol J; 2012 Aug; 9():163. PubMed ID: 22897902
[TBL] [Abstract][Full Text] [Related]
13. LASP-1, a novel urinary marker for detection of bladder cancer.
Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
[TBL] [Abstract][Full Text] [Related]
14. Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions.
Mihlan S; Reiß C; Thalheimer P; Herterich S; Gaetzner S; Kremerskothen J; Pavenstädt HJ; Lewandrowski U; Sickmann A; Butt E
Oncogene; 2013 Apr; 32(16):2107-13. PubMed ID: 22665060
[TBL] [Abstract][Full Text] [Related]
15. The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.
Segerer SE; Bartmann C; Kaspar S; Müller N; Kapp M; Butt E; Kämmerer U
Arch Gynecol Obstet; 2016 Feb; 293(2):407-14. PubMed ID: 26232936
[TBL] [Abstract][Full Text] [Related]
16. Synemin interacts with the LIM domain protein zyxin and is essential for cell adhesion and migration.
Sun N; Huiatt TW; Paulin D; Li Z; Robson RM
Exp Cell Res; 2010 Feb; 316(3):491-505. PubMed ID: 19853601
[TBL] [Abstract][Full Text] [Related]
17. [Impact of LASP-1 expression on proliferation and tumorigenesis of human colorectal cancer cell line SW480].
Zhao L; Ding YQ
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):830-4. PubMed ID: 21215099
[TBL] [Abstract][Full Text] [Related]
18. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
19. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
Zheng J; Wang F; Lu S; Wang X
Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
[TBL] [Abstract][Full Text] [Related]
20. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
